Radiation therapy in the management of diffuse large B-cell lymphoma: still relevant?
Radiation therapy in the management of diffuse large B-cell lymphoma: still relevant?
About this item
Full title
Author / Creator
Publisher
United States: Intellisphere, LLC
Journal title
Language
English
Formats
Publication information
Publisher
United States: Intellisphere, LLC
Subjects
More information
Scope and Contents
Contents
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma in the United States. Historically, radiation therapy (RT) was the primary treatment for patients with localized disease. Several randomized trials have demonstrated that the addition of systemic therapy improves outcomes. Additional randomized trials have show...
Alternative Titles
Full title
Radiation therapy in the management of diffuse large B-cell lymphoma: still relevant?
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_821974170
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_821974170
Other Identifiers
ISSN
0890-9091
